BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, February 14, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 8, 2006
View Archived Issues
rhIL-11 induces sTNFRI shedding, alleviates chemotherapy-induced mucositis
Read More
Novel approach to cancer immunotherapy with genetically engineered lymphocytes
Read More
Ghrelin analogue shows efficacy for CHF-associated cardiac cachexia
Read More
A2A receptor antagonists come forth as potential cancer immunotherapeutics
Read More
High-dose rNAPc2 improves ischemia in patients with NSTE-ACS
Read More
Salix licenses U.S. rights to Sanvar IR
Read More
Enrollment completed in phase II/III study of MN-001 in interstitial cystitis
Read More
NicOx provides full update on status of lead programs and collaborations
Read More
Clolar studied in older patients with AML
Read More
Xanthus licenses targeted cancer compounds from Schering
Read More
LX-6171 for cognitive disorders begins phase I study
Read More
Phase II trial studies CDA-1 and MDX-1388 in C. difficile associated diarrhea
Read More
GSK reports on a novel candidate for histamine H3 antagonism in AD
Read More
Phase II study evaluates R-788 for rheumatoid arthritis
Read More
Israeli approval for phase II study of CF-101 in keratoconjunctivitis sicca
Read More
Abuse resistant drug ELI-216 studied in phase II
Read More
Astellas profiles new promising agent to enhance bisphosphonate therapy in osteoporosis
Read More
AlphaVax reports phase I findings for HIV vaccine
Read More
Anthera licenses antiinflammatory compounds from Lilly and Shionogi
Read More
Dynavax and AstraZeneca collaborate on TLR-9 agonists for asthma and COPD
Read More
Laquinimod reduces rate of inflammatory disease activity in MS patients
Read More
Novel therapeutic strategies for metabolic disorders described in recent patents
Read More
Novel therapeutic agents for asthma described in recent patents
Read More
Scripps patent discloses novel transthyretin amyloid inhibitors for amyloidosis
Read More
Abbott seeks approval for Humira in Crohn's disease in U.S. and E.U.
Read More
Plavix approved in Europe for patients with STEMI
Read More
Sanofi-aventis withdraws dronedarone MAA with plans to resubmit
Read More
Takeda discontinues development of TAK-654 for diabetes
Read More
